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Abstract
Papillary glioneuronal tumor (PGNT) is a recently described lesion of the brain, which is still not
included as a separate entity in WHO classification. To date 32 cases of PGNT have been reported
in the world literature. We report the 33rd case, a 41-year-old male who presented with pain in
the nape of the neck. MRI showed a large, predominantly solid mass involving the cerebral
parenchyma of the left temporal and parieto-occipital lobes with extension across the midline.
Histologically, it was a mixture of glial and neuronal components. Architecturally, the tumor was
notable for its pseudopapillary pattern with hyalinized vessels. PGNT is considered as a low grade
neoplasm and surgical excision has been curative in most of the cases. More cases of PGNT need
to be reported as they may add further knowledge about its biologic behavior and allow its
recognition and classification.
Background
Tumors of mixed glioneuronal type like gangliocytoma,
dysembryoplastic neuroepithelial tumor, ganglioglioma,
anaplastic ganglioglioma and central neurocytoma are
well recognized in the central nervous system [1]. In the
year 1998 a new variant of mixed glioneuronal tumor was
described by Komori et al. [2] which is still not included
as a separate entity in the WHO classification. It was com-
posed primarily of glioneuronal elements with prominent
pseudopapillary structures. This unusual mixed glioneu-
ronal tumor of the central nervous system was called pap-
illary glioneuronal tumor (PGNT). The pseudopapillae
are usually composed of hyalinized vessels covered by a
single or stratified layer of glial fibrillary acid protein
(GFAP) positive astrocytes. The cells forming neuronal
elements include neurocytes, ganglioid cells or ganglion
cells within the neuropil which are synaptophysin posi-
tive. To date 32 cases of PGNT have been reported in the
world literature. We report the 33rd case with a review of
the literature.
Case presentation
The patient was a 41-year-old male who presented with
pain in the nape of the neck of one week duration in
December 2005. Also there was a history of headache on
and off for the past one year and vertigo for two and a half
years. Magnetic resonance imaging showed a predomi-
nantly solid tumor with ill defined margins. The mass
showed a heterogeneous hyper-intense signal on T2
weighted images with no obvious cystic degeneration. It
was occupying the cerebral parenchyma of the left tempo-
ral and parieto-occipital regions. There was involvement
of posterior part of body and splenium of the corpus cal-
losum with extension of the lesion across midline to the
Published: 8 February 2007
Diagnostic Pathology 2007, 2:6 doi:10.1186/1746-1596-2-6
Received: 19 December 2006
Accepted: 8 February 2007
This article is available from: http://www.diagnosticpathology.org/content/2/1/6
© 2007 Radotra et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnostic Pathology 2007, 2:6 http://www.diagnosticpathology.org/content/2/1/6
Page 2 of 5
(page number not for citation purposes)
right parietal region. The left side of midbrain, thalamus
and basal ganglia appeared distorted along with tentorial
herniation. The posterior part of the body of the left lat-
eral ventricle was compressed and the third ventricle was
displaced to the right side. The tumor was close to but did
not reach the cortical surface. Calcification and perile-
sional edema were absent (Figure 1). Craniotomy was
done with near-total excision of the tumor. There were no
post operative complications and the patient was dis-
charged after a few days. No radiotherapy was offered to
patient and there were no signs of recurrence till last fol-
low up.
Pathological findings
The excised tumor was sent for histological examination
in the form of multiple pieces. No capsule or normal look-
ing brain parenchyma could be identified. All the tissue
submitted was processed and examined. Microscopically
it was a biphasic tumor with pseudopapillary configura-
tion (Figure 2a) and focal solid pattern (Figure 2b). The
cores of the pseudopapillae showed thickened vessels
lined by single as well as stratified layers of glial cells. In
some areas these vessels exhibited marked thickening and
hyalinization with obliteration of the lumina (Figure 2c).
The solid component of the tumor was formed by sheets
of loosely placed cells with round nuclei and scanty cyto-
plasm. Focal areas formed by oligodendroglial-like,
smaller cells having clear cytoplasm were also seen. There
was no significant edema, collagen formation or inflam-
mation within the intervening gliofibrillary background.
The presence of angiomatous areas consisting of closely
placed smaller and thin walled vessels (Figure 2d) was a
unique finding in the present case. These vessels were
lined by single layer of endothelial cells with absence of
smooth muscle in their wall. These angiomatous areas
occupied about one third of the total tumor tissue. In
addition a focus of myxoid change was also seen but there
were no mature neuronal or ganglionic cells, true or
pseudo-rosettes. Mitosis, necrosis and vascular endothe-
lial proliferation were absent.
Immunohistochemically most of the glial cells forming
pseudopapillae were positive for GFAP and S-100 protein.
Neuronal cells forming solid areas were positive for syn-
aptophysin while cells lining the pseudopaillae were neg-
ative. Gliofibrillary background in the intervening areas
showed GFAP positive staining (Figure 3).
Discussion
The PGNT is a low grade neoplasm distinct from previ-
ously described variants of mixed glioneuronal tumors
because of the prominent pseudopapillary architecture
and unique clinical and radiographic features. Analysis of
all the reported cases in the literature suggests that this
tumor has no sex predilection and can affect any age
group (range 4–75 years; mean 28 years) [3,4]. Seizures
are most common and typify temporal lobe tumors,
whereas lesions at other sites usually feature headache
and nonspecific signs and symptoms. No focal deficits
have been reported so far. Occasionally the patient may be
asymptomatic [2,6]. The index case is unusual in the sense
that there was no history of seizures despite the temporal
location of the tumor. Radiologically it is almost always a
cystic lesion, usually with a mural nodule. Size of the
tumor may range from 1 cm to 7 cm (mean, 4.6 cm) [2].
The present case differs radiologically from the prior
reports in presenting without any obvious cystic change
and crossing the midline.
Histologically this tumor shows a biphasic pattern in the
form of pseudopapillae and solid areas. The solid areas
are mainly composed of neuronal elements which may be
in the form of an admixture of small, intermediate or large
cells in a fine fibrillary matrix (neuropil). A detailed
Non-contrast magnetic resonance imaging showing hyper- intense lesion involving the left temporal and parieto-occipi- tal regions Figure 1
Non-contrast magnetic resonance imaging showing hyper-
intense lesion involving the left temporal and parieto-occipi-
tal regions. The tumor is crossing the midline to the right 
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review of literature suggests that besides these features,
degenerative changes are also common in this neoplasm
(Table 1). They may be in the form of Rosenthal fibers
[2,5,7], calcification, foam cell collection, hemosiderin
laden macrophages [2,5,6,8,9] or mild lymphocytic infil-
trate [2]. All these degenerative changes were absent in the
present case. Minigemistocytic component has been
noted in one of the reported cases [9]. Ultrastructurally
[2,4] pseudopapillae contain a central vessel surrounded
by a duplicated basal lamina, a thick adventitial cuff of
collagen and another thin basal lamina separating the sur-
rounding layer of intermediate filament containing astro-
cytes. The interpapillary region contains neuronal cells.
Neurosecretory granules have not been found.
Differential diagnostic considerations include other neo-
plasms that may radiologically present as cystic masses
with a variably enhancing mural nodule, such as pilocytic
astrocytoma and ganglioglioma. The architectural similar-
ities have been noted between PGNT, central neurocy-
toma and ganglioglioma, however its geographic
limitation to the cerebrum suggests a different histogene-
sis. Other differential diagnoses include ependymoma,
extraventricular neurocytic neoplasm and dysembryoplas-
tic neuroepithelial tumor.
Treatment offered to these patients is surgical resection
and, if necessary, post operative radio- or chemo-radio-
therapy. Follow-up data range from 6 months [2] to 19
years [8] and recurrence has been reported in only one
case [9]. All the tumors described had only moderate cel-
lularity. Mitosis, necrosis and endothelial proliferation
were not seen in any of the cases. MIB-1 labeling index has
also been found to be low (0.5%–2.5%, mean 1.3%)
(a) Papillary glioneuronal tumor with pseudopapillary configuration, (b) Solid area of the tumor composed of loosely placed  cells with round nuclei and scanty cytoplasm, (c) Marked thickening and hyalinization of the vessels, (d) Angiomatous area with  vascular proliferation Figure 2
(a) Papillary glioneuronal tumor with pseudopapillary configuration, (b) Solid area of the tumor composed of loosely placed 
cells with round nuclei and scanty cytoplasm, (c) Marked thickening and hyalinization of the vessels, (d) Angiomatous area with 
vascular proliferation.Diagnostic Pathology 2007, 2:6 http://www.diagnosticpathology.org/content/2/1/6
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[2,4,7]. The presence of pseudopapillae, degenerative
changes and low MIB-1 labeling index all indicate that
PGNTs are generally slow growing and low grade neo-
plasms and thus, appear to carry a good prognosis. Since
there has been a rapid increase in the number of reported
cases of PGNT, this entity should be included as a separate
category in the WHO classification. This would facilitate
its wider recognition and help establish an evidence-based
approach to treatment.
In conclusion, we report a rare brain tumor, the PGNT in
a 41-year-old male with bilateral involvement without
any obvious cystic change. On microscopy there was
extensive angiomatous change. To the best of our knowl-
edge these changes have not been reported previously.
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The pseudopapillae formed by glial fibrillary acid protein positive cells and synaptophysin positive neuronal cells forming solid  areas Figure 3
The pseudopapillae formed by glial fibrillary acid protein positive cells and synaptophysin positive neuronal cells forming solid 
areas. GFAP = glial fibrillary acid protein, Synapto = synaptophysin.Publish with BioMed Central    and   every 
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Table 1: Pathological features of Papillary glioneuronal tumor
Pathological features Number (n = 33) 
Gross features
Cystic mass 24
Cystic with mural nodule 10
Microscopic features
Biphasic (glial & neural) 33
Pseudopapillae 33
Hyalinized vessels 28
Rosenthal fibers 13
Microcalcification 8
Pigment laden macrophages 6
Mild lymphocytic infiltrate 5
Minigemistocytes 1
Angiomatous foci 1
Immunohistochemistry
GFAP 33
S-100 31
Synaptophysin 29
Olig2 8/8
NeuN 2/2
MAP2 2/2
NCAM-L 2/2
HNK1 1/1